adjuvant treatment for early stage hormone positive breast cancer: role of genomic signatures
Published 3 years ago • 574 plays • Length 30:56Download video MP4
Download video MP3
Similar videos
-
46:31
adjuvant therapy | 2023 best of breast conference
-
2:49
procure: genomic signatures and adjuvant chemotherapy for breast cancer in europe
-
38:22
adjuvant/neoadjuvant therapy for breast cancer: updates and molecular predictors of benefit
-
28:11
2021 mdons | the nurses role in early stage breast cancer | a focus on genomic assays
-
22:47
early stage breast cancer | 2022 oneoncology conference
-
1:05:31
adjuvant therapy for early-stage her2-positive breast cancer
-
52:21
new & supporting data for optimizing therapy in her2 breast cancer | dr. irene and dr. vogel
-
41:53
guideline updates for extended endocrine therapy decision-making in hr , early-stage breast cancer
-
1:56
optimizing adjuvant treatment in hr /her2- early breast cancer
-
3:48
adjuvant therapy for breast cancer - mayo clinic
-
28:02
2022 west oncology conference | breast cancers | early-stage
-
49:25
optimizing therapy in her2 disease with dr. hope s. rugo
-
1:07:43
new & supporting data for optimizing therapy in her2 breast cancer | dr. mahtani & dr. schwartzberg
-
8:47
sramila aithal, md | neratinib and dose escalation | optimizing therapy for her2 disease
-
53:42
guideline updates for extended endocrine therapy decision-making in hr , early-stage breast cancer
-
55:48
new & supporting data for optimizing therapy in her2 breast cancer | dr. bagegni & dr. gradishar
-
2:51
breast cancer: extended adjuvant therapy and cost factors
-
31:32
2022 ku post san antonio review | early-stage hormone breast cancer: optimizing systemic therapy
-
0:55
role of chemotherapy in early hormone receptor-positive breast cancer